FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to composition with fixed dose of phytate and zinc in form of Zn2+ cation for production of medication for treatment of calcification, formed as a result of hydroxyapatite crystallisation, in particularly for prophylaxis and/or prevention of hydroxyapatite crystallisation in people. Synergism of action of composition components is shown, as a result of zinc adsorption on formed hydroxyapatite crystallisation core, which increases affinity of phytate to growing crystal, enhancing its inhibitory action on crystallisation.
EFFECT: composition increases affinity of phytate to growing crystal, enhancing its inhibitory action on crystallisation.
11 cl, 3 dwg, 2 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHOSPHATE-FREE ORAL CARE COMPOSITIONS WITH ANTIBACTERIAL AGENT OF MAGNOLIA | 2010 |
|
RU2533220C2 |
| COMPOSITION PREVENTING CALCULUS FORMATION FOR ORAL ADMINISTRATION | 1991 |
|
RU2092162C1 |
| COMPOSITIONS FOR ORAL CAVITY CARE, CONTAINING ZINC AND PHYTATE | 2006 |
|
RU2395271C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PREVENTION OF DENTAL DISEASES | 2016 |
|
RU2630612C1 |
| ORAL CARE PRODUCTS CONTAINING TETRABASIC ZINC CHLORIDE AND TRIMETHYL GLYCIN | 2012 |
|
RU2634269C2 |
| NEW APPLICATION | 2011 |
|
RU2538731C2 |
| COMPOSITIONS CONTAINING ZINK PHOSPHATE | 2017 |
|
RU2750199C2 |
| ORAL CARE COMPOSITIONS CONTAINING TIN (II) | 2006 |
|
RU2469700C2 |
| PRODUCTS FOR ORAL CARE CONTAINING TETRABASIC ZINC AMINO ACID HALOGENIDE COMPLEX | 2012 |
|
RU2625763C2 |
| ANTISEPTIC PHARMACEUTICAL COMPOSITION FOR ORAL HYGIENE AND TREATMENT OF MICROBIAL ORAL DISEASES | 2010 |
|
RU2558061C2 |
